Ardent Health, Inc.
- ARDT ยท NYSE
- Services-General Medical & Surgical Hospitals, NEC
- Brentwood, TN
- 25,200 employees
- CIK 0001756655
Updated from SEC filings through
Top things to know
Executives
-
Dave Caspers President and Chief Executive Officer of Ardent Health 8-K, 2026-11-04 - Martin Bonick President and CEO 4, 2026-04-02
-
Alfred Lumsdaine Chief Financial Officer 4, 2026-09-29 - David Raynor Byers SVP & Chief Accounting Officer 4, 2026-09-29
- David Byers Senior Vice President, Chief Accounting Officer 10-K, 2026-03-16
- Ethan Chernin President of Health Services 4, 2026-03-13
What leadership is saying
“We delivered strong third quarter results, highlighted by adjusted EBITDA of $138 million, a 4% reduction in SWB expense, and 2.9% adjusted admissions growth”
Earnings press release (8-K Ex. 99.1), filed November 4, 2026
Ardent Health, Inc. is a U.S. public company in services-general medical & surgical hospitals, nec (SIC 8062), headquartered in Brentwood, TN. It trades as ARDT on NYSE. Revenue was $6.3B in the fiscal year ending December 31, 2025, +6.0% from the year before. It reported about 25,200 employees. Dave Caspers is President and Chief Executive Officer of Ardent Health.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $6.3B 10-K, 2026-03-16 | $6.0B 10-K, 2026-03-16 | $5.4B 10-K, 2026-03-16 | $5.1B 10-K, 2025-02-27 |
| Operating income | Not on file | Not on file | Not on file | Not on file |
| SG&A | $141M 10-K, 2026-03-16 | $132M 10-K, 2026-03-16 | $115M 10-K, 2026-03-16 | $75.3M 10-K, 2025-02-27 |
| Net income | $136M 10-K, 2026-03-16 | $210M 10-K, 2026-03-16 | $53.9M 10-K, 2026-03-16 | $189M 10-K, 2025-02-27 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Dave Caspers President and CEO | President and Chief Executive Officer of Ardent Health | 8-K, 2026-11-04 |
| Martin Bonick | President and CEO | 4, 2026-04-02 |
| Alfred Lumsdaine | Chief Financial Officer | 4, 2026-09-29 |
| David Raynor Byers | SVP & Chief Accounting Officer | 4, 2026-09-29 |
| David Byers SVP CAO at Ardent Health Services | Senior Vice President, Chief Accounting Officer | 10-K, 2026-03-16 |
| Ethan Chernin | President of Health Services | 4, 2026-03-13 |
| Stephen C. Petrovich | EVP, GC and Secretary | 4, 2026-09-29 |
| Edmondo Robinson | Director | 10-K, 2026-03-16 |
| Ellen Havdala | Director | 10-K, 2026-03-16 |
| Mark Sotir | Director | 10-K, 2026-03-16 |
| Peter Bulgarelli | Director | 10-K, 2026-03-16 |
| Peter Bynoe | Director | 10-K, 2026-03-16 |
| Rahul Sen | Director | 10-K, 2026-03-16 |
| Rob DeMichiei | Director | 10-K, 2026-03-16 |
| Rob Webb | Director | 10-K, 2026-03-16 |
| Suzanne Campion | Director | 10-K, 2026-03-16 |
What Ardent Health, Inc. does
Ardent Health, Inc. was initially formed in Delaware in 2015 as Ardent Health Partners, LLC. On July 17, 2024, Ardent Health Partners, LLC converted from a Delaware limited liability company into a Delaware corporation in connection with its initial public offering and changed its name to Ardent Health Partners, Inc. On June 3, 2025, Ardent Health Partners, Inc. changed its name to Ardent Health, Inc. Ardent Health, Inc. is a holding company that has affiliates that operate acute care hospitals and other healthcare facilities and employ physicians.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 140.9 million (as of November 2, 2026) | 10-Q, November 5, 2026 |
|---|---|---|
| Public float | $324M (as of June 30, 2025) | 10-K, March 16, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting May 20, 2026 (filed April 8, 2026) | DEF 14A, April 8, 2026 |
| Auditor | Ernst & Young LLP (Nashville, Tennessee, United States of America) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| June 5, 2026 | Robert DeMichiei Director | Buy | 11,260 | $98K | Form 4, June 8, 2026 |
| June 5, 2026 | Alfred Lumsdaine Chief Financial Officer | Buy | 10,000 | $88K | Form 4, June 8, 2026 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-23
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-09-04
- Item 8.01 Other events
- 8-K filed 2026-08-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-30
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-06-02
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-26
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-03-27
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-03-04
- Item 2.02 Results of operations and financial condition (earnings release)
Frequently asked questions about Ardent Health, Inc.
- What does Ardent Health, Inc. do?
- In its own words, from Item 1 of its 10-K: "Ardent Health, Inc. was initially formed in Delaware in 2015 as Ardent Health Partners, LLC. On July 17, 2024, Ardent Health Partners, LLC converted from a Delaware limited liability company into a Delaware corporation in connection with its initial public offering and changed its name to Ardent Health Partners, Inc. On June 3, 2025, Ardent Health Partners, Inc. changed its name to Ardent Health, Inc. Ardent Health, Inc. is a holding company that has affiliates that operate acute care hospitals and other healthcare facilities and employ physicians."
- What is Ardent Health, Inc.'s revenue?
- $6.3B for the fiscal year ending December 31, 2025, from its 10-K filed March 16, 2026.
- Is Ardent Health, Inc. profitable?
- Ardent Health, Inc. reported net income of $136M for the fiscal year ending December 31, 2025.
- How many employees does Ardent Health, Inc. have?
- About 25,200 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Ardent Health, Inc.?
- Dave Caspers, President and Chief Executive Officer of Ardent Health, as named in a 8-K filed November 4, 2026.
- Who is the CFO of Ardent Health, Inc.?
- Alfred Lumsdaine, Chief Financial Officer, as named in a 4 filed September 29, 2026.
- Where is Ardent Health, Inc. headquartered?
- Brentwood, TN.
- What is Ardent Health, Inc.'s stock ticker?
- ARDT on NYSE.
- What industry is Ardent Health, Inc. in?
- Services-General Medical & Surgical Hospitals, NEC, SIC code 8062.
- What is Ardent Health, Inc.'s website?
- ardenthealth.com.
- When does Ardent Health, Inc. report earnings next?
- November 11, 2026. Source: pg_earnings_events.
- Is Ardent Health, Inc. a public company?
- Yes. Ardent Health, Inc. files with the SEC under CIK 0001756655 and trades as ARDT.
- Who audits Ardent Health, Inc.?
- Ernst & Young LLP, Nashville, Tennessee, United States of America, as named in its latest annual report (10-K).
- How many shares of Ardent Health, Inc. are outstanding?
- 140.9 million shares as of November 2, 2026, from its 10-Q filed November 5, 2026.
- What is Ardent Health, Inc.'s public float?
- $324M as of June 30, 2025, as reported on the cover of its 10-K filed March 16, 2026.
- How many business segments does Ardent Health, Inc. report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is Ardent Health, Inc.'s annual shareholder meeting?
- May 20, 2026, per its proxy statement (DEF 14A) filed April 8, 2026.
- Have Ardent Health, Inc. insiders traded stock recently?
- Since June 5, 2026, officers and directors reported 0 open-market sales and 2 purchases worth about $186K on Forms 4 and 5. The most recent: Robert DeMichiei (Director) bought 11,260 shares on June 5, 2026.